Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy

[1] Arriagada R(2004)Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 351-360

[2] Bergman B(2006)Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 719-727

[3] Dunant A(2008)Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group J Clin Oncol 26 3552-3559

[4] Le Chevalier T(2010)Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data Lancet 375 1267-1277

[5] Pignon JP(1980)Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design Int J Radiat Oncol Biol Phys 6 983-986

[6] Vansteenkiste J(2006)Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database J Clin Oncol 24 2998-3006

[7] Douillard JY(2008)Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial Int J Radiat Oncol Biol Phys 72 695-701

[8] Rosell R(2000)A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial Int J Radiat Oncol Biol Phys 47 925-929

[9] De Lena M(2007)Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung J Thorac Oncol 2 1098-1102

[10] Carpagnano F(2010)Current status of postoperative radiation for non-small-cell lung cancer Semin Radiat Oncol 20 192-200

[1] Arriagada R(2004)Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 351-360

[2] Bergman B(2006)Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 719-727

[3] Dunant A(2008)Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group J Clin Oncol 26 3552-3559

[4] Le Chevalier T(2010)Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data Lancet 375 1267-1277

[5] Pignon JP(1980)Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design Int J Radiat Oncol Biol Phys 6 983-986

[6] Vansteenkiste J(2006)Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database J Clin Oncol 24 2998-3006

[7] Douillard JY(2008)Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial Int J Radiat Oncol Biol Phys 72 695-701

[8] Rosell R(2000)A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial Int J Radiat Oncol Biol Phys 47 925-929

[9] De Lena M(2007)Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung J Thorac Oncol 2 1098-1102

[10] Carpagnano F(2010)Current status of postoperative radiation for non-small-cell lung cancer Semin Radiat Oncol 20 192-200